Diabetes Treatment

Buccal drug-delivery company working on glucose spray

Published in Obesity and Diabetes Week, November 29th, 2004

Generex Biotechnology Corp. (GNBT), a buccal drug-delivery company, said it is actively engaged in the research and development of GlucoSpray, a proprietary oral glucose spray formulation, to be delivered by way of the company's proprietary RapidMist device.

Regulation of blood glucose levels is necessary for good health. For patients with diabetes, regulating blood glucose levels to achieve targets is problematic, particularly for patients with type 1 diabetes undergoing aggressive insulin therapy.

Glucose can be replaced with food, juice, candy, or glucose tablets or solutions if time is not an issue and the patient is cooperative and can swallow....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-11-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry